B. Riley Wealth Advisors’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $70.8K | Buy |
+18,288
| New | +$70.8K | ﹤0.01% | 937 |
|
2024
Q4 | $176K | Buy |
24,454
+1,000
| +4% | +$7.21K | 0.01% | 1052 |
|
2024
Q3 | $144K | Buy |
23,454
+2,687
| +13% | +$16.5K | ﹤0.01% | 1179 |
|
2024
Q2 | $138K | Buy |
+20,767
| New | +$138K | ﹤0.01% | 1284 |
|
2022
Q1 | – | Sell |
-34,000
| Closed | -$312K | – | 1383 |
|
2021
Q4 | $312K | Sell |
34,000
-1,227
| -3% | -$11.3K | 0.01% | 1045 |
|
2021
Q3 | $399K | Sell |
35,227
-19,153
| -35% | -$217K | 0.01% | 892 |
|
2021
Q2 | $536K | Buy |
54,380
+20,830
| +62% | +$205K | 0.02% | 736 |
|
2021
Q1 | $475K | Buy |
33,550
+900
| +3% | +$12.7K | 0.02% | 756 |
|
2020
Q4 | $369K | Buy |
+32,650
| New | +$369K | 0.02% | 647 |
|